US FDA revises label warnings in erectile dysfunction drugs
Friday, October 26, 2007 15:00 IST Maryland
The US Food and Drug Administration has approved labelling changes for erectile dysfunction (ED) drugs in the class that includes Cialis, Levitra, and Viagra, to display more prominently the potential risk of sudden hearing loss